Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...
Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.
First for Women on MSN20h
Ozempic Now FDA-Approved for Kidney Disease-Here's What to KnowGLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...
Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...
Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...
January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.
Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...
News Medical on MSN13h
Neoantigen vaccine sparks powerful immune defense against kidney cancerA personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...
Intensive blood pressure control in hypertensive chronic kidney disease (CKD) provides a survival advantage and other benefits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback